Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C.
Go back to Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C.| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 42.09 +0.62 (1.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.47 | 52 Week High | $66.55 | |||
| Open | $41.17 | 52 Week Low | $37.82 | |||
| Day High | $42.59 | P/E | N/A | |||
| Day Low | $41.17 | EPS | $0.00 | |||
| Volume | 7,357,778 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 42.09 +0.62 (1.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.47 | 52 Week High | $66.55 | |||
| Open | $41.17 | 52 Week Low | $37.82 | |||
| Day High | $42.59 | P/E | N/A | |||
| Day Low | $41.17 | EPS | $0.00 | |||
| Volume | 7,357,778 | |||||



